Search research articles
Contact Us
Filters
Showing results (51-60 of 99) with videos related to
Page
of 10
Sort By:
Scientific Reports
|
March 22, 2025
Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumors
Margherita Iaboni, Federico Crivellin, Francesca Arena, et al.
Nature Communications
|
September 23, 2015
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Sandra Misale, Ivana Bozic, Jingshan Tong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 19, 2024
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
Marco Cortese, Erica Torchiaro, Alice D'Andrea, et al.
Cancers
|
August 7, 2021
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways
Federica Invrea, Simona Punzi, Consalvo Petti, et al.
The Journal of Clinical Investigation
|
July 29, 2010
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
Andrea Casazza, Veronica Finisguerra, Lorena Capparuccia, et al.
Nature Communications
|
November 11, 2024
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts
Umberto Perron, Elena Grassi, Aikaterini Chatzipli, et al.
Nature Genetics
|
September 30, 2016
Corrigendum: Stromal contribution to the colorectal cancer transcriptome
Claudio Isella, Andrea Terrasi, Sara Erika Bellomo, et al.
Nature Genetics
|
February 24, 2015
Stromal contribution to the colorectal cancer transcriptome
Claudio Isella, Andrea Terrasi, Sara Erika Bellomo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas
Giorgia Migliardi, Francesco Sassi, Davide Torti, et al.
Cancer Research
|
December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 99) with videos related to
Sort By:
Page
of 10
Scientific Reports
|
March 22, 2025
Complete preclinical evaluation of the novel antibody mimetic Nanofitin-IRDye800CW for diverse non-invasive diagnostic applications in the management of HER-2 positive tumors
Margherita Iaboni, Federico Crivellin, Francesca Arena, et al.
Nature Communications
|
September 23, 2015
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers
Sandra Misale, Ivana Bozic, Jingshan Tong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 19, 2024
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
Marco Cortese, Erica Torchiaro, Alice D'Andrea, et al.
Cancers
|
August 7, 2021
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways
Federica Invrea, Simona Punzi, Consalvo Petti, et al.
The Journal of Clinical Investigation
|
July 29, 2010
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice
Andrea Casazza, Veronica Finisguerra, Lorena Capparuccia, et al.
Nature Communications
|
November 11, 2024
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts
Umberto Perron, Elena Grassi, Aikaterini Chatzipli, et al.
Nature Genetics
|
September 30, 2016
Corrigendum: Stromal contribution to the colorectal cancer transcriptome
Claudio Isella, Andrea Terrasi, Sara Erika Bellomo, et al.
Nature Genetics
|
February 24, 2015
Stromal contribution to the colorectal cancer transcriptome
Claudio Isella, Andrea Terrasi, Sara Erika Bellomo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 7, 2012
Inhibition of MEK and PI3K/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas
Giorgia Migliardi, Francesco Sassi, Davide Torti, et al.
Cancer Research
|
December 21, 2013
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas
Dario Sangiolo, Giulia Mesiano, Loretta Gammaitoni, et al.
Page
of 10